Tiziana Life Sciences Ltd Cash And Cash Equivalents
Tiziana Life Sciences Ltd (TLSA) had Cash And Cash Equivalents of $3.72 million as of 2024-12-31, per its 20-F/A filed 2025-05-08.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2025-05-08
- 2024-12-31: Cash And Cash Equivalents $3.72M.
- 2023-12-31: Cash And Cash Equivalents $1.18M.
- 2022-12-31: Cash And Cash Equivalents $18.12M.
- 2021-12-31: Cash And Cash Equivalents $42.19M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2024-12-31 | $3.72M 20-F/A · filed 2025-05-08 |
| 2023-12-31 | $1.18M 20-F/A · filed 2025-05-08 |
| 2022-12-31 | $18.12M 20-F/A · filed 2025-05-08 |
| 2021-12-31 | $42.19M 20-F/A · filed 2025-05-08 |
| 2020-12-31 | $65.82M 20-F · filed 2024-05-10 |
| 2019-12-31 | $200.00K 20-F/A · filed 2023-06-13 |
| 2018-12-31 | $5.30M 20-F · filed 2022-05-23 |
| 2017-12-31 | $64.00K 20-F · filed 2021-05-17 |
| 2016-12-31 | $5.80M 20-F · filed 2020-06-17 |
| 2015-12-31 | $13.13M 20-F · filed 2019-04-04 |